Back to the main directory
Press Release
- Capital Southwest Receives Affirmed Investment Grade Rating from Moody’s Investors Service by GlobeNewsWire
- ADT Strengthens Executive Leadership Team with Appointments of Fawad Ahmad as Chief Operating and Customer Officer and Omar Khan as Chief Business Officer by GlobeNewsWire
- Regeneron to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2025 by GlobeNewsWire
- Tenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update by GlobeNewsWire
- Polyrizon Expands Drug Delivery Innovation with Preclinical Studies for Epilepsy Rescue Treatment by GlobeNewsWire
- OrthoPediatrics Corp. to Participate in the 24th Annual Needham Virtual Healthcare Conference by GlobeNewsWire
- Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date March 14, 2025 by GlobeNewsWire
- Evolution Petroleum Announces Upcoming Investor Events by GlobeNewsWire
- Elutia Advances Scientific Leadership with Publication of New Study on Antibiotic-Eluting Biologic Envelope by GlobeNewsWire
- LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock by GlobeNewsWire
- Nortech Systems Incorporated to Report Fourth Quarter 2024 Financial Results and Hold a Conference Call on March 31, 2025 by GlobeNewsWire
- GameStop Announces Update to its Investment Policy to Add Bitcoin as a Treasury Reserve Asset by GlobeNewsWire
- Americold Announces Pricing Terms for $400,000,000 Notes Offering by GlobeNewsWire
- Worthington Enterprises Reports Third Quarter Fiscal 2025 Results by GlobeNewsWire
- Stryker announces Annual Meeting of Shareholders by GlobeNewsWire
- WeRide Inc. Files Its 2024 Annual Report on Form 20-F by GlobeNewsWire
- Evaxion to present new phase 2 data for AI-designed personalized cancer vaccine EVX-01 at AACR Annual Meeting by GlobeNewsWire
- Nokia Oyj: Omien osakkeiden takaisinosto 25.03.2025 by GlobeNewsWire
- Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025 by GlobeNewsWire
- Nurix Therapeutics Announces Multiple Presentations at the American Association for Cancer Research (AACR) 2025 Annual Meeting by GlobeNewsWire
- Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline with Five Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025 by GlobeNewsWire
- Olema Oncology to Present Preclinical Data for OP-3136, a Potent KAT6 Inhibitor, Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at the 2025 AACR Annual Meeting by GlobeNewsWire
- Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025 by GlobeNewsWire
- Zymeworks to Present Preclinical Data on T cell Engager and Antibody-Drug Conjugate Platforms in Six Posters at AACR Annual Meeting by GlobeNewsWire
- Farmers & Merchants Bancorp, Inc. Declares 2025 First-Quarter Cash Dividend by GlobeNewsWire